HRT with a history of endometriosis: could it wake my endo back up?

Your caution rests on something real. Endometriosis is an estrogen-dependent disease: its lesions feed partly on estrogen ^[2]. It affects around 1 in 10 women of reproductive age ^[1]. Your fear isn't exaggerated or irrational.

But there's a world between "feed on" and "reignite everything." With a history of endometriosis, lesions persist or recur in roughly 2 to 4% of cases, sometimes even without any treatment ^[5][6]. Out of 100 women in your situation, the large majority don't see their endo flare back up.

One key nuance: endometriosis can persist after menopause, independent of any HRT. Lesions make their own estrogen on site, thanks to an enzyme called aromatase ^[7]. Falling hormones often calm symptoms, but they don't guarantee the lesions are gone ^[5].

The most feared risk, malignant transformation of lesions, exists but stays very rare (under 1% of cases, mostly on estrogen alone) ^[6]. It's not inevitable. It's one more reason to avoid estrogen on its own and to keep up follow-up.

Picture your lesions as plants that love one fertilizer: estrogen. Giving estrogen alone is watering them with no counterweight. That's "unopposed" estrogen, the one that raises the risk of waking lesions up ^[8].

A progestogen acts like a brake: it calms the stimulation of cells. That's why, with a history of endo, most guidelines prefer combined HRT (estrogen paired with a progestogen) over estrogen alone ^[3][5].

Here's the surprising part: even after the uterus is removed (a hysterectomy, the surgical removal of the uterus), a progestogen is often still advised ^[3]. Usually it's no longer needed after that operation. But with endo, lesions live outside the uterus: removing it doesn't clear everything. The progestogen keeps braking any residual lesions.

There's also tibolone, a synthetic steroid that relieves symptoms while barely stimulating the womb lining, sometimes raised as an alternative ^[9]. Worth discussing with your doctor.

The second major lever: how estrogen enters your body. Swallowing a pill (oral route) or applying a gel or patch to the skin (transdermal route) aren't the same thing. Swallowed, estrogen passes through the liver first, which triggers the production of clot-promoting factors. Through the skin, it reaches the blood without that detour: less clot risk ^[4].

In 2025, France's health authority (HAS) reaffirmed the skin route, preferring it for estrogen, at the lowest effective dose ^[4]. A recent, solid reference point to lean on.

For your endo, this minimal-dose logic limits how much estrogen reaches any residual lesions. The overall benefit-risk profile also depends on your age and how long it's been since menopause ^[10]. All of these are open to discussion, not fixed.

A safety point that works for you: with a history of endo, HRT is decided with a doctor, one case at a time, never on your own ^[3]. HRT isn't a contraceptive, it makes up for the menopause hormone drop without preventing pregnancy ^[4]. That medical framework turns a vague risk into a managed decision.

If you'd rather avoid hormones, alternatives exist: some prescription medications, cognitive behavioural therapy, or local treatments for dryness. Whether they fit depends on your situation and is decided with your doctor ^[4].

Questions to bring along:

• "Given my endo history, do you recommend combined HRT rather than estrogen alone, even after surgery?"
• "Can we favour the skin route, gel or patch?"
• "What's the lowest effective dose for my hot flashes?"
• "What signals should alert me, and how often will you follow up?"

Your second asset is your history: your past pain, where it sat, your surgeries, what relieved you. The more precise that story, the more tailored the decision. Logging your symptoms week by week spares you from reconstructing ten years from memory in the room, and gives your doctor dated facts.